PIIIW Selling And Marketing Expenses from 2010 to 2024

PIIIW Stock  USD 0.01  0.0005  4.42%   
P3 Health Selling And Marketing Expenses yearly trend continues to be fairly stable with very little volatility. Selling And Marketing Expenses will likely drop to about 3.1 M in 2024. During the period from 2010 to 2024, P3 Health Selling And Marketing Expenses regression line of quarterly data had mean square error of 250052.5 T and geometric mean of  4,555,528. View All Fundamentals
 
Selling And Marketing Expenses  
First Reported
2010-12-31
Previous Quarter
3.2 M
Current Value
3.1 M
Quarterly Volatility
528 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check P3 Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among P3 Health's main balance sheet or income statement drivers, such as Depreciation And Amortization of 91 M, Interest Expense of 15.2 M or Selling General Administrative of 116.2 M, as well as many indicators such as Price To Sales Ratio of 0.0932, Dividend Yield of 0.0 or PTB Ratio of 0.83. PIIIW financial statements analysis is a perfect complement when working with P3 Health Valuation or Volatility modules.
  
Check out the analysis of P3 Health Correlation against competitors.

Latest P3 Health's Selling And Marketing Expenses Growth Pattern

Below is the plot of the Selling And Marketing Expenses of P3 Health Partners over the last few years. It is P3 Health's Selling And Marketing Expenses historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in P3 Health's overall financial position and show how it may be relating to other accounts over time.
Selling And Marketing Expenses10 Years Trend
Slightly volatile
   Selling And Marketing Expenses   
       Timeline  

PIIIW Selling And Marketing Expenses Regression Statistics

Arithmetic Mean202,047,114
Geometric Mean4,555,528
Coefficient Of Variation261.34
Mean Deviation346,823,170
Median1,870,004
Standard Deviation528,037,241
Sample Variance278823.3T
Range1.5B
R-Value0.41
Mean Square Error250052.5T
R-Squared0.17
Significance0.13
Slope48,286,516
Total Sum of Squares3903526.6T

PIIIW Selling And Marketing Expenses History

20243.1 M
20233.2 M
20211.5 B
20201.5 M
2019801.7 K

About P3 Health Financial Statements

P3 Health investors use historical fundamental indicators, such as P3 Health's Selling And Marketing Expenses, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in P3 Health. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Selling And Marketing Expenses3.2 M3.1 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for PIIIW Stock Analysis

When running P3 Health's price analysis, check to measure P3 Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy P3 Health is operating at the current time. Most of P3 Health's value examination focuses on studying past and present price action to predict the probability of P3 Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move P3 Health's price. Additionally, you may evaluate how the addition of P3 Health to your portfolios can decrease your overall portfolio volatility.